Snakebite management in India, the first few hours: a guide for primary care physicians.

J Indian Med Assoc

WHO Snakebite Treatment Group, Nayathode.

Published: June 2007


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Snakebite in India continues to be a matter of medical concern and India remains amongst the group of countries with the highest mortality. India is also one of the world's leading producers of snake venom antiserum and therefore the understanding of the causals of snakebite mortality does not rest in snake venom antiserum shortages. The availability of treatment, particularly close to the scene of the bite, is a crucial factor in ensuring a positive outcome. In the majority of the States in India, 90+% of medical facilities are primary healthcare centres run by one doctor and with only basic equipment. If snakebite treatment is to be successful, these centres are a vital element, but virtually all existing treatment guides assume treatment at tertiary care hospitals with better equipment. A great many of these primary care hospitals do not treat snakebite, even when snake venom antiserum is available, simply because the doctor lacks confidence in being able to treat the patient. The result is that patients are referred to distant, better equipped hospitals and thus make journeys without the cover of snake venom antiserum. This paper provides guidance for the primary healthcare doctor in identification of medically significant snakes, treatment, referral criteria and equipment necessary to successfully manage snakebite in a primary care environment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

snake venom
16
venom antiserum
16
primary care
12
primary healthcare
8
care hospitals
8
snakebite
6
india
5
primary
5
treatment
5
snakebite management
4

Similar Publications

Exploring the antiangiogenic effects of Phospholipases A from Bothrops diporus venom.

Cell Tissue Res

September 2025

Grupo de Investigaciones Biológicas y Moleculares (GIByM), Instituto de Química Básica y Aplicada del Nordeste Argentino (IQUIBA NEA), Universidad Nacional del Nordeste (UNNE)-CONICET, Corrientes, Argentina.

Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a crucial process in both physiological and pathological contexts, including cancer. Phospholipases A (PLAs), enzymes found in snake venoms, have attracted attention due to their potential antiangiogenic properties. In this study, we explored the antiangiogenic effects of PLA isoforms isolated from Bothrops diporus venom using a combination of in vivo and ex vivo models.

View Article and Find Full Text PDF

Snake envenomation is a neglected tropical disease with two million snake bites reported each year (WHO). Much less common is snake venom ophthalmia secondary to eye exposure from spitting snakes. This paper reports an unusual case of systemic envenomation via the ocular route of a 14-year old male from the Philippines.

View Article and Find Full Text PDF

IMRC-Exo mitigates venom-induced limb injury in rabbits by inhibiting GSDME-dependent pyroptosis.

J Venom Anim Toxins Incl Trop Dis

September 2025

Department of Emergency, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, Zhejiang, China.

Background: Inflammation plays a critical role in the pathogenesis of limb injury caused by snakebite. Investigating its regulatory mechanisms and intervention strategies may help identify effective treatments. Recent studies have shown that pyroptosis exacerbates organ damage by amplifying inflammatory responses.

View Article and Find Full Text PDF

Snake envenoming is a relevant public health issue, especially in tropical regions worldwide. Bothrops venom is essential for antivenom production in Brazil; however, the impacts of hepatic neoplasms on venom composition remain unexplored. This study aimed to evaluate whether hepatic neoplasms and/or cysts influence the biochemical profile and enzymatic activity of venoms from five Bothrops species.

View Article and Find Full Text PDF

To evaluate the efficacy and clinical application value of mouse nerve growth factor combined with neostigmine in the treatment of nerve injury in patients bitten by Bungarus multicinctus by a prospective single-blind controlled clinical study. In June 2020, a prospective, single-blindness, randomized grouping method was used to select patients with bungarus multicinctus saurogobio dabryi subsp. dabryi bite injuries admitted to the Emergency Department of Ganzhou People's Hospital in Jiangxi Province as the study subjects.

View Article and Find Full Text PDF